These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26036857)

  • 1. Towards a European consensus for reporting incidental findings during clinical NGS testing.
    Hehir-Kwa JY; Claustres M; Hastings RJ; van Ravenswaaij-Arts C; Christenhusz G; Genuardi M; Melegh B; Cambon-Thomsen A; Patsalis P; Vermeesch J; Cornel MC; Searle B; Palotie A; Capoluongo E; Peterlin B; Estivill X; Robinson PN
    Eur J Hum Genet; 2015 Dec; 23(12):1601-6. PubMed ID: 26036857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.
    Elfatih A; Mohammed I; Abdelrahman D; Mifsud B
    Physiol Genomics; 2021 Sep; 53(9):373-384. PubMed ID: 34250816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing.
    Allyse M; Michie M
    Trends Biotechnol; 2013 Aug; 31(8):439-41. PubMed ID: 23664778
    [No Abstract]   [Full Text] [Related]  

  • 4. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
    Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
    Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHATIF: An open-source desktop application for extraction and management of the incidental findings from next-generation sequencing variant data.
    Ye Z; Kadolph C; Strenn R; Wall D; McPherson E; Lin S
    Comput Biol Med; 2016 Jan; 68():165-9. PubMed ID: 25890833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACMG clinical laboratory standards for next-generation sequencing.
    Rehm HL; Bale SJ; Bayrak-Toydemir P; Berg JS; Brown KK; Deignan JL; Friez MJ; Funke BH; Hegde MR; Lyon E;
    Genet Med; 2013 Sep; 15(9):733-47. PubMed ID: 23887774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current controversies in prenatal diagnosis 2: The 59 genes ACMG recommends reporting as secondary findings when sequencing postnatally should be reported when detected on fetal (and parental) sequencing.
    Amor DJ; Chitty LS; Van den Veyver IB
    Prenat Diagn; 2020 Dec; 40(12):1508-1514. PubMed ID: 32091628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical exome performance for reporting secondary genetic findings.
    Park JY; Clark P; Londin E; Sponziello M; Kricka LJ; Fortina P
    Clin Chem; 2015 Jan; 61(1):213-20. PubMed ID: 25414276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel.
    Vears DF; Sénécal K; Borry P
    Hum Mutat; 2017 Aug; 38(8):905-911. PubMed ID: 28512758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for returning genomic incidental findings? We need to talk!
    Burke W; Antommaria AH; Bennett R; Botkin J; Clayton EW; Henderson GE; Holm IA; Jarvik GP; Khoury MJ; Knoppers BM; Press NA; Ross LF; Rothstein MA; Saal H; Uhlmann WR; Wilfond B; Wolf SM; Zimmern R
    Genet Med; 2013 Nov; 15(11):854-9. PubMed ID: 23907645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular findings among patients referred for clinical whole-exome sequencing.
    Yang Y; Muzny DM; Xia F; Niu Z; Person R; Ding Y; Ward P; Braxton A; Wang M; Buhay C; Veeraraghavan N; Hawes A; Chiang T; Leduc M; Beuten J; Zhang J; He W; Scull J; Willis A; Landsverk M; Craigen WJ; Bekheirnia MR; Stray-Pedersen A; Liu P; Wen S; Alcaraz W; Cui H; Walkiewicz M; Reid J; Bainbridge M; Patel A; Boerwinkle E; Beaudet AL; Lupski JR; Plon SE; Gibbs RA; Eng CM
    JAMA; 2014 Nov; 312(18):1870-9. PubMed ID: 25326635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
    Ploug T; Holm S
    PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
    Evans BJ
    Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics professionals' perspectives on reporting incidental findings from clinical genome-wide sequencing.
    Lohn Z; Adam S; Birch P; Townsend A; Friedman J
    Am J Med Genet A; 2013 Mar; 161A(3):542-9. PubMed ID: 23401068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.
    Bennette CS; Gallego CJ; Burke W; Jarvik GP; Veenstra DL
    Genet Med; 2015 Jul; 17(7):587-95. PubMed ID: 25394171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.